Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Borstkanker Onderzoek Groep
Borstkanker Onderzoek Groep
Network · 8 registered clinical trials.
Status
Trial
Phase
Started
Active Not Recruiting
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
Neoplasm, Breast, Congenital, Familial and Genetic Disorders
Phase 2
2022-06-02
Active Not Recruiting
TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer
Breast Neoplasm, Chemotherapy Effect
Phase 2
2020-09-25
Active Not Recruiting
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
Breast Neoplasms
Phase 2
2019-06-15
Active Not Recruiting
Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study
Breast Cancer
Phase 2
2019-02-27
Withdrawn
Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer
Breast Neoplasms
Phase 2
2018-02-01
Active Not Recruiting
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Ca
Breast Neoplasm Female
Phase 3
2017-11-09
Completed
8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Metastatic Breast Cancer
Phase 3
2010-11-01
Completed
Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patien
Breast Cancer
Phase 3
2010-04-01